Supplemental material, Suppl_Fig._1 for The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib by Wenxia Wang, Swati Bhattacharyya, Roberta Goncalves Marangoni, Mary Carns, Kathleen Dennis-Aren, Anjana Yeldandi, Jun Wei and John Varga in Journal of Scleroderma and Related Disorders
Wang, W. (Creator), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. (Creator), Wei, J. (Creator), Varga, J. (Creator), Faivre, J. C. (Contributor) (2019). Suppl_Fig._1 – Supplemental material for The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib. SAGE Journals. 10.25384/sage.9375521